Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Teresa Macarulla »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Teresa Lamb < Teresa Macarulla < Teresa Mascarenhas  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000774 (2016) Andrea Wang-Gillam [États-Unis] ; Chung-Pin Li [Taïwan] ; György Bodoky [Hongrie] ; Andrew Dean [Australie] ; Yan-Shen Shan [Taïwan] ; Gayle Jameson [États-Unis] ; Teresa Macarulla [Espagne] ; Kyung-Hun Lee [Corée du Sud] ; David Cunningham [Royaume-Uni] ; Jean F. Blanc [France] ; Richard A. Hubner [Royaume-Uni] ; Chang-Fang Chiu [Taïwan] ; Gilberto Schwartsmann [Brésil] ; Jens T. Siveke [Allemagne] ; Fadi Braiteh [États-Unis] ; Victor Moyo [États-Unis] ; Bruce Belanger [États-Unis] ; Navreet Dhindsa [États-Unis] ; Eliel Bayever [États-Unis] ; Daniel D. Von Hoff [États-Unis] ; Li-Tzong Chen [Taïwan]Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
000A38 (2016) Eric Van Cutsem [Belgique] ; Florence Joulain [France] ; Paulo M. Hoff [Brésil] ; Edith Mitchell [États-Unis] ; Paul Ruff [Afrique du Sud] ; Radek Lakom [République tchèque] ; Jana Prausová [République tchèque] ; Vladimir M. Moiseyenko [Russie] ; Guy Van Hazel [Australie] ; David Cunningham [Royaume-Uni] ; Dirk Arnold [Allemagne] ; Hans-Joachim Schmoll [Allemagne] ; Albert J. Ten Tije [Pays-Bas] ; Joseph Mckendrick [Australie] ; Hendrik Kröning [Allemagne] ; Yves Humblet [Belgique] ; Cristina Grávalos [Espagne] ; Solenn Le-Guennec [France] ; Michael Andria [États-Unis] ; Emmanuelle Dochy [Belgique] ; Raghu L. Vishwanath [États-Unis] ; Teresa Macarulla [Espagne] ; Josep Tabernero [Espagne]Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy.
000B15 (2015) Paul Ruff [Afrique du Sud] ; David R. Ferry [Royaume-Uni] ; Radek Lakom [République tchèque] ; Jana Prausová [République tchèque] ; Guy A. Van Hazel [Australie] ; Paulo M. Hoff [Brésil] ; David Cunningham [Royaume-Uni] ; Dirk Arnold [Allemagne] ; Hans J. Schmoll [Allemagne] ; Vladimir M. Moiseyenko [Russie] ; Joseph J. Mckendrick [Australie] ; Albert J. Ten Tije [Pays-Bas] ; Raghu L. Vishwanath [États-Unis] ; Pankaj Bhargava [États-Unis] ; Soazig Chevalier [France] ; Teresa Macarulla [Espagne] ; Eric Van Cutsem [Belgique]Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
3Camptothecin (analogs & derivatives)
3Female
3Humans
3Male
2Aged
2Antineoplastic Combined Chemotherapy Protocols (pharmacology)
2Camptothecin (administration & dosage)
2Camptothecin (adverse effects)
2Camptothecin (pharmacology)
2Camptothecin (therapeutic use)
2Fluorouracil (administration & dosage)
2Fluorouracil (adverse effects)
2Fluorouracil (pharmacology)
2Fluorouracil (therapeutic use)
2Leucovorin (administration & dosage)
2Leucovorin (adverse effects)
2Leucovorin (pharmacology)
2Leucovorin (therapeutic use)
2Middle Aged
2Neoplasm Metastasis
2Organoplatinum Compounds (therapeutic use)
2Receptors, Vascular Endothelial Growth Factor (therapeutic use)
2Recombinant Fusion Proteins (therapeutic use)
2Treatment Outcome
1Adult
1Aged, 80 and over
1Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Biomarkers, Pharmacological
1Carcinoma, Pancreatic Ductal (drug therapy)
1Carcinoma, Pancreatic Ductal (mortality)
1Colorectal Neoplasms (drug therapy)
1Colorectal Neoplasms (mortality)
1Colorectal Neoplasms (pathology)
1Deoxycytidine (administration & dosage)
1Deoxycytidine (adverse effects)
1Deoxycytidine (analogs & derivatives)
1Diarrhea (chemically induced)
1Disease Progression
1Disease-Free Survival
1Double-Blind Method
1Fatigue (chemically induced)
1Kaplan-Meier Estimate
1Liposomes
1Neoplasm Recurrence, Local (drug therapy)
1Neutropenia (chemically induced)
1Organoplatinum Compounds (administration & dosage)
1Organoplatinum Compounds (pharmacology)
1Pancreatic Neoplasms (drug therapy)
1Pancreatic Neoplasms (mortality)
1Proportional Hazards Models
1Receptors, Vascular Endothelial Growth Factor (administration & dosage)
1Receptors, Vascular Endothelial Growth Factor (adverse effects)
1Receptors, Vascular Endothelial Growth Factor (pharmacology)
1Recombinant Fusion Proteins (administration & dosage)
1Recombinant Fusion Proteins (adverse effects)
1Recombinant Fusion Proteins (pharmacology)
1Survival Analysis
1Vomiting (chemically induced)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Teresa Macarulla" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Teresa Macarulla" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Teresa Macarulla
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024